Insights Archive

The COVID-19 crisis has stressed the human and financial capital of our healthcare system. A quick return to business as usual is unlikely. Many of the effects of the pandemic will persist and healthcare customer needs will have changed. Suppliers in tune with the current/new needs of healthcare providers can outperform competitors.

Retrospectively, it is clear that in every economic/market downturn, some companies took aggressive actions that enabled them to outperform competitors during the ensuing rebound. In January 2020, every healthcare CEO anticipated a good year ahead....

Following more than 200 meetings by FSI’s senior team at the JP Morgan Conference, we identified a shared perspective on the opportunities and challenges for the year ahead.

​

​

How are health systems managing the recovery process? What are the longer-term implications for medical device, telehealth, and digital health companies? Fletcher Spaght surveyed 100 hospital CEO’s and CFO’s about their COVID-19 outlook for 2H’2020 and beyond.

With former Cleveland Clinic CEO, Toby Cosgrove, MD and Fletcher Spaght Managing Partner, John Fletcher

When will elective procedures resume? What are the strategic and financial implications for medical device, telehealth, and digital health companies? Fletcher Spaght surveyed 100 hospital CEO’s and CFO’s about their COVID-19 outlook for 2H’2020 and beyond.

“I am grateful to receive NACD’s Director of The Year Award; this tremendous honor is reflective of the tremendous success of the executives and co-directors with whom I worked.” – John Fletcher